Beranda › Mieloma Multipel › New Jersey › Edison
Uji klinis Mieloma Multipel di Edison, NJ
22 studi untuk Mieloma Multipel mencari peserta di lokasi sekitar Edison (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Menerima pesertaFase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauhnya
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 3
- Astera Cancer Care, East Brunswick · 6 mi jauhnya
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Menerima pesertaFase 3
- Astera Cancer Care, East Brunswick · 6 mi jauhnya
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Menerima pesertaFase 3
- MSK Basking Ridge, Basking Ridge · 15 mi jauhnya
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Menerima pesertaFase 4
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Menerima pesertaFase 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi jauhnya
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Menerima pesertaFase 3
- MSK Basking Ridge, Basking Ridge · 15 mi jauhnya
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Menerima pesertaFase 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauhnya
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Menerima pesertaFase 3
- Research Site, East Brunswick · 6 mi jauhnya
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Menerima pesertaStudi observasional
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauhnya
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Menerima pesertaFase 1/2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauhnya
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Menerima pesertaFase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauhnya
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Menerima pesertaFase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauhnya
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
Menerima pesertaFase awal 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick · 3 mi jauhnya
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Menerima pesertaFase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 1
- Rutgers Cancer Institute of New Jersey /ID# 266833, New Brunswick · 3 mi jauhnya
A Dietary Study for People With Multiple Myeloma
Menerima peserta
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauhnya
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Menerima pesertaFase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Menerima pesertaFase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauhnya
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauhnya
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Menerima peserta
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi jauhnya
Uji klinis Mieloma Multipel di kota lain
- New York City, NY60 studi
- Boston, MA42 studi
- Atlanta, GA41 studi
- Houston, TX38 studi
- Durham, NC37 studi
- Nashville, TN32 studi
- Denver, CO27 studi
- Rochester, MN24 studi
- St. Louis, MO24 studi
- Columbus, OH24 studi
- Baldwin Park, CA23 studi
- Chicago, IL22 studi
Studi lain di Edison
- Kanker Payudara68 studi
- Kanker Paru Non-Sel Kecil47 studi
- Kanker (semua jenis)33 studi
- Kanker Prostat29 studi
- Kanker Kolorektal23 studi
- Kanker Paru23 studi
- Kanker Kandung Kemih21 studi
- Kanker Metastatik20 studi
- Kanker Ovarium20 studi
- Leukemia Mieloid Akut20 studi
- Kanker Endometrium19 studi
- Karsinoma Urotelial (Sel Transisional)18 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.